Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 11.39% vs 14.83% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -8.50% vs -39.68% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -2.08% vs -18.37% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -13.76% vs -23.57% in Mar 2025
Compare Profit and Loss Results of Star Health Insu
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
17,370.00
25.00
17,345.00
69,380.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
17,370.00
25.00
17,345.00
69,380.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1,983.00
6.00
1,977.00
32,950.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
0.00
15.00
-15.00
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-43.00
0.00
-43.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
16,872.00
22.00
16,850.00
76,590.91%
Operating Profit (PBDIT) excl Other Income
498.00
3.00
495.00
16,500.00%
Other Income
463.00
4.00
459.00
11,475.00%
Operating Profit (PBDIT)
962.00
8.00
954.00
11,925.00%
Interest
128.00
0.00
128.00
0%
Profit before Depriciation and Tax
833.00
8.00
825.00
10,312.50%
Depreciation
79.00
0.00
79.00
0%
Profit Before Taxation & Exceptional Items
754.00
7.00
747.00
10,671.43%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
754.00
7.00
747.00
10,671.43%
Provision for Tax
197.00
1.00
196.00
19,600.00%
Profit After Tax
556.00
5.00
551.00
11,020.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
359.00
1,829.00
-1,470.00
-80.37%
Profit Available for appropriations
916.00
1,835.00
-919.00
-50.08%
Appropriations
916.00
1,835.00
-919.00
-50.08%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
9.47
0.17
9.30
5,470.59%
Profit And Loss - Net Sales
Net Sales 17,370.92 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.39% vs 14.83% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 498.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -8.50% vs -39.68% in Mar 2025
Profit And Loss - Interest
Interest 128.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.08% vs -18.37% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 556.98 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -13.76% vs -23.57% in Mar 2025






